Suchergebnisse - "Blatt, Lawrence M"

PubPharm (30)

1

An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients

enthalten in: Antiviral research | 2024

von Debing, Y. | Vanrusselt, H. | Degrauwe, L. | +20

2

Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles

enthalten in: Journal of virology | 2023

von Vanrusselt, H. | Kum, D. | Taverniti, V. | +14

3

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir

enthalten in: mBio | 2023

von Jochmans, D. | Liu, C. | Donckers, K. | +22

4

Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development

enthalten in: Antiviral research | 2021

von Liu, C. | Boland, S. | Scholle, M. | +10

5

Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry

enthalten in: Antiviral research | 2020

von Gurard-Levin, Z. | Liu, C. | Jekle, A. | +12

6

Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Patel, K. | Kirkpatrick, C. | Nieforth, K. | +10

7

Short-Duration AL-335, Odalasvir, With or Without Simeprevir, in Patients With HCV GT1 or 3 Infection Without Cirrhosis

enthalten in: Hepatology (Baltimore, Md.) | 2018

von Gane, E. | Stedman, C. | Schwabe, C. | +6

8

Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects

enthalten in: PloS one | 2018

von McClure, M. | Berliba, E. | Tsertsvadze, T. | +13

9

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

enthalten in: The New England journal of medicine | 2015

von DeVincenzo, J. | McClure, M. | Symons, J. | +9

CommentIn: N Engl J Med. 2016 Apr 7;374(14):1391-2. - PMID 27050226

10

Development of a Hyperglycosylated IFN Alfacon-1 (CIFN) : Toward Bimonthly or Monthly Dosing for Antiviral Therapies

enthalten in: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research | 2015

von Taylor, J. | Zhang, Q. | Julander, J. | +8